title: [Ciprofloxacin in urinary infections: analysis of the Italian data pool].
abstract: Efficacy and safety of oral ciprofloxacin (500-1000 mg/die) were evaluated in 231 patients with bacteriologically documented infections of the urinary tract. The clinical resolution rate was 89.6% with eradication of the aetiological organism in 90.1% of cases. Superinfection, both bacterial or fungal, as well as side-effects were minimal. It is concluded that ciprofloxacin represents an effective and safe therapy in urinary tract infections.
authors.forename: F
authors.initials: F
authors.lastname: Maggiolo
authors.forename: W
authors.initials: W
authors.lastname: Bianchi
authors.forename: H
authors.initials: H
authors.lastname: Ohnmeiss
mesh_terms: D000284:Administration, Oral; D000328:Adult; D001424:Bacterial Infections / Q000188:drug therapy*; D002939:Ciprofloxacin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D015337:Multicenter Studies as Topic; D014552:Urinary Tract Infections / Q000188:drug therapy*
chemical_list: D002939:Ciprofloxacin
vernacular_title: Ciprofloxacin nelle infezioni urinarie: analisi del data-pool italiano.